2.86
price down icon1.04%   -0.03
after-market After Hours: 2.86
loading
Organogenesis Holdings Inc stock is traded at $2.86, with a volume of 306.46K. It is down -1.04% in the last 24 hours and down -0.69% over the past month. Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
See More
Previous Close:
$2.89
Open:
$2.89
24h Volume:
306.46K
Relative Volume:
0.46
Market Cap:
$378.50M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
35.05
EPS:
0.0816
Net Cash Flow:
$6.55M
1W Performance:
+1.42%
1M Performance:
-0.69%
6M Performance:
+0.70%
1Y Performance:
-10.06%
1-Day Range:
Value
$2.835
$2.96
1-Week Range:
Value
$2.765
$3.00
52-Week Range:
Value
$1.96
$4.705

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Name
Name
Organogenesis Holdings Inc
Name
Phone
781-575-0775
Name
Address
85 DAN ROAD, CANTON, MA
Name
Employee
862
Name
Twitter
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
ORGO's Discussions on Twitter

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-10-22 Downgrade BTIG Research Buy → Neutral
Aug-10-22 Downgrade Oppenheimer Outperform → Perform
Jan-10-20 Initiated SVB Leerink Outperform
Aug-26-19 Resumed Credit Suisse Outperform
May-02-19 Initiated Credit Suisse Outperform
Apr-17-19 Initiated Oppenheimer Outperform
Apr-11-19 Initiated SunTrust Buy
View All

Organogenesis Holdings Inc Stock (ORGO) Latest News

pulisher
03:35 AM

Healthy Upside Potential: Organogenesis Holdings Inc (ORGO) - SETE News

03:35 AM
pulisher
Sep 28, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Down 16.5% in September - MarketBeat

Sep 28, 2024
pulisher
Sep 23, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Massachusetts Financial Services Co. MA - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Bank of New York Mellon Corp Increases Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

WINTON GROUP Ltd Sells 4,139 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Are Organogenesis Holdings Inc’shares a good deal? - US Post News

Sep 19, 2024
pulisher
Sep 16, 2024

Wealth Dimensions Group Ltd. Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat

Sep 16, 2024
pulisher
Sep 11, 2024

Acadian Asset Management LLC Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Sep 11, 2024
pulisher
Sep 09, 2024

Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S - Simply Wall St

Sep 09, 2024
pulisher
Sep 09, 2024

Wound Care Biologics Market Business Strategies, Share, Growth - openPR

Sep 09, 2024
pulisher
Sep 05, 2024

Ratio Revelations: Organogenesis Holdings Inc (ORGO)’s Financial Metrics in the Spotlight - The Dwinnex

Sep 05, 2024
pulisher
Sep 04, 2024

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - ForexTV.com

Sep 04, 2024
pulisher
Sep 04, 2024

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - Yahoo Finance UK

Sep 04, 2024
pulisher
Sep 04, 2024

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Organogenesis Holdings Inc’s results are impressive - US Post News

Sep 04, 2024
pulisher
Aug 28, 2024

Comprehensive Study of Asia Pacific Wound Care Biologics Market - openPR

Aug 28, 2024
pulisher
Aug 26, 2024

There is no doubt that Organogenesis Holdings Inc (ORGO) ticks all the boxes. - SETE News

Aug 26, 2024
pulisher
Aug 21, 2024

Examining Organogenesis Holdings Inc (ORGO) stock is warranted - US Post News

Aug 21, 2024
pulisher
Aug 19, 2024

Financial Analysis: Organogenesis Holdings Inc (ORGO)’s Ratios Unveil Key Insights - The Dwinnex

Aug 19, 2024
pulisher
Aug 19, 2024

Organogenesis Holdings Inc (ORGO) expanding its growth trajectory ahead - SETE News

Aug 19, 2024
pulisher
Aug 17, 2024

Assenagon Asset Management S.A. Purchases 3,005,450 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat

Aug 17, 2024
pulisher
Aug 15, 2024

Vanguard Group Inc. Sells 1,825,428 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

Vanguard Group Inc. Sells 1,825,428 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

Organogenesis Holdings Inc (ORGO) presents a great opportunity, but the stock is slightly overvalued - US Post News

Aug 14, 2024
pulisher
Aug 14, 2024

Company’s Banking Shares: Up -43.46% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle

Aug 14, 2024
pulisher
Aug 14, 2024

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionORGO - Marketscreener.com

Aug 14, 2024
pulisher
Aug 13, 2024

Market Highlights: Organogenesis Holdings Inc (ORGO) Ends on a Low Note at 2.42 - The Dwinnex

Aug 13, 2024
pulisher
Aug 13, 2024

Organogenesis Holdings Second Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.04 profit in 2Q 2023) - Simply Wall St

Aug 13, 2024
pulisher
Aug 12, 2024

Organogenesis Holdings Inc (ORGO) can make a big difference with a little luck - SETE News

Aug 12, 2024
pulisher
Aug 10, 2024

Organogenesis Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Aug 10, 2024
pulisher
Aug 10, 2024

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 10, 2024
pulisher
Aug 09, 2024

Earnings call: Organogenesis exceeds Q2 revenue expectation at $130.2 million - Investing.com

Aug 09, 2024
pulisher
Aug 09, 2024

Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results - ForexTV.com

Aug 09, 2024
pulisher
Aug 09, 2024

Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail

Aug 09, 2024
pulisher
Aug 09, 2024

Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail

Aug 09, 2024
pulisher
Aug 09, 2024

Organogenesis (ORGO) Q2 2024 Earnings Call Transcript - The Motley Fool

Aug 09, 2024
pulisher
Aug 09, 2024

Organogenesis: Q2 Earnings Snapshot - San Antonio Express-News

Aug 09, 2024
pulisher
Aug 09, 2024

Organogenesis (ORGO) Q2 2024 Earnings Call Transcript - AOL

Aug 09, 2024
pulisher
Aug 08, 2024

Organogenesis Holdings, Inc. (ORGO) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 08, 2024
pulisher
Aug 08, 2024

Organogenesis nears BLA submission for knee OA treatment - Investing.com India

Aug 08, 2024
pulisher
Aug 08, 2024

Organogenesis: Q2 Earnings Snapshot - San Francisco Chronicle

Aug 08, 2024
pulisher
Aug 08, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Aug 08, 2024
pulisher
Aug 08, 2024

Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results - wallstreet:online

Aug 08, 2024
pulisher
Aug 08, 2024

Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

Organogenesis Shares ReNu® Program Update - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

Results from Organogenesis Holdings Inc (ORGO) show risk - US Post News

Aug 08, 2024
pulisher
Aug 08, 2024

Selling Organogenesis Holdings Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St

Aug 08, 2024
pulisher
Aug 07, 2024

Balance Sheet Dive: Organogenesis Holdings Inc (ORGO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Aug 07, 2024
pulisher
Aug 07, 2024

Stem Cell Therapy for Wound Healing Market to Witness Astonishing Growth by 2031 | Organogenesis Holdings Inc., Osiris Therapeutics, Inc. – TIMC - TIMC

Aug 07, 2024
pulisher
Aug 06, 2024

Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail

Aug 06, 2024
pulisher
Aug 05, 2024

Church & Dwight Company (CHD-N) QuotePress Release - The Globe and Mail

Aug 05, 2024

Organogenesis Holdings Inc Stock (ORGO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$109.75
price up icon 2.23%
$73.17
price down icon 0.18%
$60.57
price up icon 0.40%
$115.22
price up icon 0.14%
drug_manufacturers_specialty_generic RDY
$79.45
price down icon 0.28%
$11.61
price up icon 0.52%
Cap:     |  Volume (24h):